Submitted:
03 June 2025
Posted:
11 June 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Litterature Review
- Literature search
- Study Selection
- Data Collection
- Data synthesis and analysis
2.2. Monocentric Retrospective Analysis
- Study design
- Eligibility criteria
- Data collection
- Demographic data: age, sex, occupation, laterality (in the case of upper limb involvement).
- Complication risk factors: history of diabetes, smoking, major comorbidities.
- Tumor characteristics: Breslow index, sentinel lymph node status if present.
- Excision strategy: excision margins applied.
- Reconstruction strategy: number of stages, reconstruction time, technique used, operating time.
- Post-operative follow-up: occurrence of any major complications (infection, hematoma, failure of the reconstruction) or minor complications (early consultation, disunion, healing problems, return to the operating theatre for secondary touch-up).
- Duration of post-operative follow-up.
- -
- Damage to the upper limb was assessed by the Quick DASH (score from 0 to 100) and the Modified Mayo Wrist Score (score from 0 to 100).
- -
- Damage to the lower limbs was assessed using the AOFAS score (American Orthopedic Foot and Ankle Score; score from 0 to 90).
3. Results
- Study selection
- Study characteristics
- Demographic characteristics
- Anatomical localisation
- Melanoma type
- Margins
- Strategy for reconstruction
- Post-operative complications
- 2 transit metastases, one of which was treated surgically (17, 22)
- 10 lymph node involvement (17, 21)
- 11 visceral metastases, resulting in 2 deaths (17, 19, 20, 25).
- Residual nail spicules were reported in 15 patients (13, 15, 16, 18) and epidermal cysts in 13 patients (13-15, 18). Other adverse events included:
- 10 cases of hypersensitivity to cold or shock;
- 9 cases of graft hyperpigmentation (13);
- 1 case of distal interphalangeal arthritis (29);
- 1 flexor sheath hematoma (24);
- 1 case of temporary functional exclusion of the finger (14).
- Complementary treatments
- Functional and cosmetic results
- Post-operative follow-up
| Ref. |
Type of arti- cle Number of patients Distribution Mean age (years) (range) |
Localisa-tion F (Finger) T (Toe) (n) |
Local ex- tension |
Presence of previous biopsy Margins from Nail apparatus |
Strategy of econstruction Surgical management |
Side effects, Complications |
Complemen- tary treatment |
Results | Follow up mean (range) |
| Anda- Juarez et al, An Bras Derma- tol, 2016 | Retrospective 15 patients (9F, 6M) 31 (4-66) |
Right hand: F2(2), F4(2), F5(1) Left hand: F1 (1), F5 (3) Right foot (5): T1 (5) Left foot (1): T1 |
SUM in situ | 5 mm Supra periosteum re- section |
FTSG (14) Banner flap (1 patient) |
No recurrence Inclusion cysts (4) Spicules (6) Hypersensitivity (4) Moderate chronic pain (1) Hyperpigmentation of the skin graft (9) |
NA | Functional and cos- metic outcome was good in all of them | 55 months (12-98) |
| Lazar et al, Hand- Surg Br, 2005 | Retrospective 13 patients (8F, 5M) 10 patients with SUM (7F, 3M) 40 (NA) |
Right hand F1(3), F3(1), F5(1) Left hand: F1 (2), F5(3) |
SUM in situ | 5 mm | Immediate FTSG harvested from same forearm (9) Delayed FTSG harvested from same forearm (1) | Temporary finger exclu- sion (1case) Epidermal cyst (5 cases) |
NA | Sensitivity: Weber 4- 6mm (7), NA (1) Normal function (4), Slightly limited function (5), NA (1) Cosmetic outcome: Satisfied or normal (9), NA (1) |
48 months (6 – 84) |
| Puhain- dran et al, Tech Hand Up Ex- trem Surg, 2011 | Retrospective 10 patients (4F, 6 M) 6 patients with a SUM MA 52 (24-80) |
NA | SUM in situ, <2cm diame- ter |
2 mm to nail fold | Immediate FTSG | Positive margin (1), treated by PID Disartic- ulation Secondary surgery: Epidermal inclusion cyst (1) Nail remnant (1) |
NA | Acceptable appear- ance for all patients (assessed by 2 sur- geons) Patients satisfied (6) Unrestricted use of the hand (6) |
35 months (8-72) |
| Flores- Terry et al, Actas Dermo- sifiliogr, 2018 | Retrospective 11 patients 7 patients with SUM (4F, 3M) 5 patients (3F, 2M) treated by WLE 61 (45-81) |
Right hand: F2(1) F3(1) Left hand F1(1) F2(1) Right foot: T1 (1) |
SUM in situ (4) or Sum with Breslow <1 mm (1) |
Previous biopsy 5 mm Supra periosteum re- section |
Circumferential advance- ment flap and Immediate FTSG |
No recurrency (5) Wound infection (2) subungual spicules (1), moderate stiffness of DIP of one finger (1) hy- persensitivity to cold (2), hypersensitivity to mild trauma (4) |
NA | Patients were satis- fied with the proce- dure and the results obtained (5) Satisfaction was good and the impact on quality of life was minimal (5) |
39 months (12-96) |
| Moehrle et al, Derma- tol Surg, 2003 | Retrospective 62 patients with SUM (25H, 37F) 31 treated by WLE (11 H, 20F) MA 61 |
F1,2,3,4,5(20) T1,2,3,4,5 (11) |
SUM in situ Invasive SUM Breslow < 1mm (6) Breslow 1 to 2mm (8) Breslow 2 to 4mm (6) Breslow > 4mm (4) NA: (7) |
5 mm WLE with safety margin without bone resection (3) WLE with safety margin with resec- tion of the distal part of the distal phalanx (28) |
FTSG with pulpal advance- ment flap Single stage (1) Several stages (30) Unspecified reconstruction after definitive three-dimen- sional histology |
Recurrencies (20 pa- tients) Local recurrence (2) In transit recurrence (1) Lymph node metastasis (7) Distant metastasis (1) |
NA | Function and cosme- sis of the involved finger or toe « pre- served » | 54 months (NA) |
| Goett- mann et al, J Eur Acad Derma- tol Ve- nereol, 2018 | Retrospective 63 patients (44F, 19M) 58 treated by WLE 51 (NA) |
F1 (24) F2,3,4,5 (23) T1 (10) T3(1) |
All SUM, if pulp not in- volved | No previous biopsy WLE (12) Partial excision of the appliance removing the lesion, and the nearby paronychium (47) |
Healing by secondary inten- tion (52) FTSG (3 patients) Flap (1) |
Local recurrences at 24 and 32 months treated by amputation (2) Spicules (7) Epidermal cysts (2) |
NA | No functional dis- comfort (20) Moderate discom- fort (14) Aesthetic discomfort was judged to be absent (29) Moderate aes- thetic discomfort (8) Severe aesthetic dis- comfort (2) |
120 months (NA) |
| Chow et al, J Plast Re- constru Surg, 2013 | Case report 1 M with SUM in situ 41 |
Right T1 (1) | SUM in situ | Biopsy 10 mm WLE with a layer of bone |
Immediate FTSG (harvested from the groin) | NA | NA | Acceptable cosmetic result (assessed by surgeon) | 5 months |
| Duarte et al, Derma- tol, 2010 | Case report 1 F with SUM in situ 61 |
Right F1 (1) | SUM in situ | Excisional biopsy 3 weeks later 3 mm margin WLE |
FTSG taken from the arm | No local recurrence or metastasis | NA | Thumb function completely pre- served | 12 months |
| High et al, Arch Derma- tol, 2004 | Retrospective 7 patients (5F, 2M) with SUM in situ 4 patients treated by WLE MA 56 (NA) |
Right hand (1): F2 Left hand (2): F2(1), F5(1) Right foot (1): T1(1) |
SUM in situ | Previous biopsy MOHS surgery: 1 stage (3) 2 stages (1) |
FTSG taken from the arm (3) cross finger flap (1) | Recurrence: (1) treated by revisional amputa- tion | NA | NA | 24 months (10-29) |
| Sinno et al, J Plast Surg Hand Surg, 2015 | Retrospective 35 patients with melanoma of the hand (24F, 11M) 18 patients with SUM 10 patients with SUM treated by WLE |
F1 (8) F2 (12) F3(3) F5(3) |
Melanomas in situ (7) Invasive Melanoma T2(1 pa- tients) B=2.5mm Invasive Melanoma T3 (2); B=3.00mm and B=3.08mm |
5 mm | FTSG (3) Paronychial advancement flap + FTSG (3) Paronychial advancement flap + forearm flap + FTSG (1) Paronychial advancement flap + FTSG Volar Flap FTSG (1) FTSG Volar and dorsal ad- vancement flaps (1) FTSG Local advancement flap (1) |
Revisional amputation (3) Unknow (1) Deceased (1) |
NA | NA | 47 months (7–74) |
| Smock et al, J Plast Re- constr Aesthet Surg, 2010 |
Case report 1 M 44 |
Right F1 (1) | Ulcerated SUM Bres- low of 1.2 mm | Previous Biopsy 10 mm, including the periosteum |
Immediate reconstruction by dermal matrix (INTEGRA) STSG 3 weeks later | None | NA | Fully functional thumb and a good cosmetic result Went back to job at 4 weeks | 24 months |
| Bjedov et al, Acta Dermato Venereol Croat, 2019 | Case report (1) F, 31 |
Left F1 (1) | SUM in situ | Several nail matrix biopsies 5 mm, with perios- teum Mohs analysis |
Pedicled innervated Fascio cutaneous Foucher's flap Donor site was covered with a FTSG taken from the volar side of the elbow. | None | NA | The hand was fully functional, and the patient was very sat- isfied with the ap- pearance of the thumb Full sensory cortical reorientation |
3 months |
| Oh et al, J Am Acad Derma- tol, 2023 | Retrospective 140 patients with SUM 107 with con- servative treat- ment (57 F, 50 H) Mean age: 56 |
F1,2,3,4,5 (71) T1,2,3,4,5 (36) |
If no bone invasion (MRI + bi- opsy) |
Biopsy and MRI at least 3 to 4 mm, with periosteum | NA | Recurrency (23 pa- tients): Local recurrence (15) Distant recurrences (8) |
NA | NA | 45 months (14- 76) |
| Motta et al, Arch Derma- tol, 2007 | Case report 12 years old, F | Right F1 (1) | SUM in situ | Biopsy WLE with Mohs Mi- crographic analysis 5-10mm (lateral) 5 mm (proximal and distal edges) |
Two stages Second stage (1week later) microvascular composite on- ycho-cutaneous free flap from the right first toe |
NA | NA | Normal nail growth and full mobility of the interphalangeal thumb joint were present | 3 months |
| Wollina et al, Derma- tol Ther, 2019 | Retrospective Serie of 12 pa- tients with SUM) 6 patients with conservative treatment (2F, 4M) 76 (NA) |
Right foot T1(2) T3 (1) Left foot: T1 (3) |
SUM with Breslow be- tween 1.6 mm to 4.8 mm |
Wide excision (4) Excision with de- layed Mohs surgery (2) | Full thickness skin trans- plantation. One patient refused, second intention healing |
Local relapse (2) Later metastasis () Satellites only (1 pa- tient, B=2.55) Liver, pancreas, spleen, lymph nodes, stomach, adrenal glands, greater omentum, CNS (1, with Breslow =4.8mm) In transit, lymph node regional, pericardium (1, with Breslow=3.20) |
Sentinel Lymph node (4), with micro-invasion (1) Polychemother- apy for later me- tastasis (1) Transit metasta- ses treated by er- bium YAG-laser as a palliative measure (1) interferon-alfa therapy for 9 years after sur- gery satellites metastasis (1) Adjuvant radio- therapy (1) |
NA | 104 months (17 -208) |
| Crisan et al, Acad Derma- tol Ve- nereol, 2017 |
Retrospective Serie of 7 pa- tients (3F, 4H) 64 (NA) |
F1 (3) F4 (3) T1 (1) |
SUM in situ pT1a (1) pT1b (1) |
WLE (7) NA | First stage: vacuum-assisted closure Second stage: FTSG (5) |
Second stage amputa- tion (2 patients) for: -DIP joint arthritis (1) -Positive margin (1) |
NA | At 6 weeks, the 5 pa- tients grafted could resume normal ac- tivity Good cosmetic and functional |
12 months (NA) |
| Lee et al, Plast Re- constr Surg, 2017 |
Prospective 41 patients with conservative |
Fingers: 25 Toes: 16 |
SUM with Breslow thickness of ≤ 2 mm on |
Preoperative biopsy 5-mm with perios- teum excise (10 mm margin if in- vasive lesion) |
Immediate reconstruction by SCIP flap with a final thick- ness ranging from 1.5 to 4 mm after defatting | Necrosis of the flap (1) (arterial insufficiency) Venous congestion (3) with partial necrosis of the flap |
NA | Average healing time: 15 days Questionnaire car- ried out on 26 | 31 months (NA) |
| treatment (21M, 20F) 51.1 (NA) |
preoperative biopsy | (Scouted with Doppler) End to end anastomosis with digital artery and dorsal vein Donor site primary closing |
Seroma of the donor site (1) Recurrences: -local recurrence (1) -metastasis in transit (1) Second surgical stage until degreasing (12) |
patients: WLE in the upper limb (14): The mean Quick- DASH score was 1.3 (range 0 to 6.8). WLE in the lower limb (12): FFI survey for foot lesions, mean score was 3.1 (range 0 to 8.0) |
|||||
| Hayashi et al, Derma- tol Surg, 2012 | Case report (1M), 52 | Left F3 | SUM in situ | No biopsy 5 mm with excision of periosteum |
Immediate reconstruction with artificial dermis (PELNAC) Second stage at 4 weeks with FTSG |
No recurrency No metastasis | NA | Good cosmetic re- sults | 3 months |
| Sureda et al, Br J Derma- tol, 2011 | Retrospective Serie of 7 patients (5F, 2M) MA 58 y |
F1(2), F2(2), F4(1) T1 (2) |
SUM in situ (5) or minimally invasive SUM (2) (Breslow 0.2 and 0.15) |
Biopsy systematically 5-10 mm Deep margin was bone contact |
Immediate FTSG taken from the internal aspect of an arm | No recurrence | NA | Interrogation of pa- tient and observer: High level of satis- faction, a good func- tional and quite good cosmetic re- sult. | 45 months (24-84) |
| Nec- zyporen ko et al, J Eur Acad Derma- tol Ve- nereol, 2014 |
Retrospective Serie of 11 pa- tients (8 F, 3 M) 48 (NA) |
Right hand: F1(3), F2(1), F5(1) Left hand: F1(1) F2(1) T1(3), T2(1) |
Melanoma in situ | Biopsy systematically (tangential or punch) 6 mm | Immediate FTSG (6) Secondary intention and de- layed FTSG (5) |
Tendon sheath haema- toma (1) Lymphangitis post (1) Recurrence treated by secondary amputation and sentinel node (2) (7- and 11-years post op) |
NA | Healing by second- ary intention and grafting were fully satisfactory, cosmet- ically and function- ally | 65 months (5-167) |
| Terush- kin et al, Derma- tol Surg, 2016 | Retrospective Serie of 40 pa- tients (21 F,19M) 63 (NA) |
NA | WLE in cases of ex- tensive SUM (>40% of the bed) |
Excisional biopsy with Mohs micro- graph, Supra Periosteum dissection |
Second intention FTSG STSG | Recurrences (5) Second operation with com- plete excision of the ma- trix (2) Amputation (2) Death due to metastasis (1) |
NA | NA | 76 months (2-276) |
| Rayatt et al, Plast Reconstr Aesthet Surg, 2007 | Retrospective Serie of 4 pa- tients 56 (NA) |
F1 (4) | SUM with- out deep margin clini- cally in- volved Breslow 0.9m m to 4mm |
All had initial biop- sies to confirm the di- agnosis 10 mm including the periosteum |
Immediate: -Foucher flap (1) -Flag flap (2) Delayed reconstruction (flag flap) (1) |
Recurrence at 36 months treated by am- putation (1) | NA | Usefully maintain function. | 72 months (-117) |
| Imakado et al, J Derma- tol, 2008 | Retrospective Serie of 2 pa- tients (1M, 1F) 50 |
Left F3 (1) Right F5(1) | SUM in situ | All the nail apparatus with nail folds | Immediate FTSG | No recurrence | NA | NA | 27 months (6 -48) |
| Liu et al, Medic- ina, 2020 | Retrospective Serie of 4 patients with malignant tumour of nail apparatus 3 patients with SUM suspicion (1F, 2M) MA 55 y |
Left T1 (1) Right T1 (2) |
SUM in situ (2) hyperpig- mentation in basal layer of epidermis (1) |
Previous biopsy (2) WLE Adequate margin control confirmed by intraoperative frozen sections |
Two stages reconstruction Immediate acellular dermal matrix (PELNAC) At 10 days, the acellular der- mal matrix was removed and re-dressed in a new one at the outpatient clinic FTSG at 3 weeks |
No Recurrence | NA | These patients expe- rienced minimal change in body con- tour, mild but ac- ceptable functional deficit, and satisfy- ing aesthetic results. | 9 months (5-13) |
Retrospective Monocentric Study of a Series of Patient
Population Characteristics
Per-Operative Data
Post-Operative Data






4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
| SUM | Subungueal melanoma |
| WLE | Wide local excision (of nail apparatus) |
| F | Finger |
| T | Toe |
| FTSG | Full thickness skin graft |
| STSG | Split thickness skin graft |
| NA | Non available |
| COPD | Chronic obstructive pulmonary disease |
| ScoreQuick DASH | score Quick Disabilities of the arm, shoulder and hand, (score ranges from 0, no obstacles to 100, maximum obstacles) |
| MMWS | score ranging from 0, maximum disability, to 100, no disability |
| Score AO- FAS | the American Orthopedic Foot and Ankle Score (score ranging from 0, maximum disability, to 90, no disability) |
References
- Cancer IAfRo. https://gco.iarc.who.int/today/ 2022.
- Breslow A. Tumor thickness in evaluating prognosis of cutaneous melanoma. Ann Surg. 1978;187(4):440.
- Feibleman CE, Stoll H, Maize JC. Melanomas of the palm, sole, and nailbed: a clinicopathologic study. Cancer 1980;46(11):2492-504.
- Brodland DG. The treatment of nail apparatus melanoma with Mohs micrographic surgery. Dermatol Surg. 2001;27(3):269-73.
- Haneke, E. Ungual melanoma - controversies in diagnosis and treatment. Dermatol Ther. 2012;25(6):510-24.
- Nakamura Y, Ohara K, Kishi A, Teramoto Y, Sato S, Fujisawa Y, et al. Effects of non-amputative wide local excision on the local control and prognosis of in situ and invasive subungual melanoma. J Dermatol. 2015;42(9):861-6.
- Cochran AM, Buchanan PJ, Bueno RA, Jr., Neumeister MW. Subungual melanoma: a review of current treatment. Plast Reconstr Surg. 2014;134(2):259-73.
- Temple-Oberle C, Nicholas C, Rojas-Garcia P. Current Controversies in Melanoma Treatment. Plast Reconstr Surg. 2023;151(3):495e-505e.
- Baran R G-BSMI, Robert C. Traitement du mélanome de l’appareil unguéal. Annales de Dermatologie et de Vénéréologie. 2021;Vol 1 - N° 2:P. 128-32.
- Hovgaard C, Angermann P, Hovgaard D. The social and economic consequences of finger amputations. Acta Orthop Scand. 1994;65(3):347-8.
- Poumellec MA, Camuzard O, Dumontier C. Hook nail deformity. Hand Surg Rehabil. 2024;43s:101649.
- Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. 2021;372:n71.
- Anda-Juárez MC, Martínez-Velasco MA, Fonte-Ávalos V, Toussaint-Caire S, Domínguez-Cherit J. Conservative surgical management of in situ subungual melanoma: long-term follow-up. An Bras Dermatol. 2016;91(6):846-8.
- Lazar A, Abimelec P, Dumontier C. Full thickness skin graft for nail unit reconstruction. J Hand Surg Br. 2005;30(2):194-8.
- Puhaindran ME, Cordeiro PG, Disa JJ, Mehrara BJ, Athanasian EA. Full-thickness skin graft after nail complex resection for malignant tumors. Tech Hand Up Extrem Surg. 2011;15(2):84-6.
- Flores-Terry M, Romero-Aguilera G, Mendoza C, Franco M, Cortina P, Garcia-Arpa M, et al. Functional Surgery for Malignant Subungual Tumors: A Case Series and Literature Review. Actas Dermosifiliogr (Engl Ed). 2018;109(8):712-21.
- Moehrle M, Metzger S, Schippert W, Garbe C, Rassner G, Breuninger H. "Functional" surgery in subungual melanoma. Dermatol Surg. 2003;29(4):366-74.
- Goettmann S, Moulonguet I, Zaraa I. In situ nail unit melanoma: epidemiological and clinic-pathologic features with conservative treatment and long-term follow-up. J Eur Acad Dermatol Venereol. 2018;32(12):2300-6.
- Sinno S, Wilson S, Billig J, Shapiro R, Choi M. Primary melanoma of the hand: An algorithmic approach to surgical management. J Plast Surg Hand Surg. 2015;49(6):339-45.
- Oh BH, Lee S, Park JW, Lee JY, Roh MR, Nam KA, et al. Risk of recurrence of nail unit melanoma after functional surgery versus amputation. J Am Acad Dermatol. 2023;88(5):1017-23.
- Wollina U, Tempel S, Hansel G. Subungual melanoma: A single center series from Dresden. Dermatol Ther. 2019;32(5):e13032.
- Lee KT, Park BY, Kim EJ, Kim JH, Jang KT, Choi SH, et al. Superthin SCIP Flap for Reconstruction of Subungual Melanoma: Aesthetic Functional Surgery. Plast Reconstr Surg. 2017;140(6):1278-89.
- Sureda N, Phan A, Poulalhon N, Balme B, Dalle S, Thomas L. Conservative surgical management of subungual (matrix derived) melanoma: report of seven cases and literature review. Br J Dermatol. 2011;165(4):852-8.
- Neczyporenko F, André J, Torosian K, Theunis A, Richert B. Management of in situ melanoma of the nail apparatus with functional surgery: report of 11 cases and review of the literature. J Eur Acad Dermatol Venereol. 2014;28(5):550-7.
- Terushkin V, Brodland DG, Sharon DJ, Zitelli JA. Digit-Sparing Mohs Surgery for Melanoma. Dermatol Surg. 2016;42(1):83-93.
- Rayatt SS, Dancey AL, Davison PM. Thumb subungual melanoma: is amputation necessary? J Plast Reconstr Aesthet Surg. 2007;60(6):635-8.
- Imakado S, Sato H, Hamada K. Two cases of subungual melanoma in situ. J Dermatol. 2008;35(11):754-8.
- Liu TH, Hsieh MC, Chou PR, Huang SH. Reconstruction for Defects of Total Nail Bed and Germinal Matrix Loss with Acellular Dermal Matrix Coverage and Subsequently Skin Graft. Medicina (Kaunas). 2020;56(1).
- Crisan D, Gülke J, Janetzko C, Kastler S, Treiber N, Scharffetter-Kochanek K, et al. Digit preserving surgery of subungual melanoma: a case series using vacuum assisted closure and full-thickness skin grafting. J Eur Acad Dermatol Venereol. 2017;31(12):e537-e8.
- High WA, Quirey RA, Guillén DR, Munõz G, Taylor RS. Presentation, histopathologic findings, and clinical outcomes in 7 nail unit. Arch Dermatol. 2004;140(9):1102-6.
- Chow WT, Bhat W, Magdub S, Orlando A. In situ subungual melanoma: digit salvaging clearance. J Plast Reconstr Aesthet Surg. 2013;66(2):274-6.
- Duarte AF, Correia O, Barros AM, Azevedo R, Haneke E. Nail matrix melanoma in situ: conservative surgical management. Dermatology. 2010;220(2):173-5.
- Smock ED, Barabas AG, Geh JL. Reconstruction of a thumb defect with Integra following wide local excision of a subungual melanoma. J Plast Reconstr Aesthet Surg. 2010;63(1):e36-7.
- Bjedov S, Ježić I, Bulić K. Reconstruction of a Thumb Defect Following Subungual Melanoma Resection Using Foucher's Flap. Acta Dermatovenerol Croat. 2019;27(1):51-2.
- Motta A, López C, Acosta A, Peñaranda C. Subungual melanoma in situ in a Hispanic girl treated with functional resection and reconstruction with onychocutaneous toe free flap. Arch Dermatol. 2007;143(12):1600-2.
- Hayashi K, Uhara H, Koga H, Okuyama R, Saida T. Surgical treatment of nail apparatus melanoma in situ: the use of artificial dermis in reconstruction. Dermatol Surg. 2012;38(4):692-4.
- A. B. A fungus hematode du petit doigt. Gaz Med. 1834;1834:212.
- Levit EK, Kagen MH, Scher RK, Grossman M, Altman E. The ABC rule for clinical detection of subungual melanoma. J Am Acad Dermatol. 2000;42(2 Pt 1):269-74.
- Tran KT, Wright NA, Cockerell CJ. Biopsy of the pigmented lesion--when and how. J Am Acad Dermatol. 2008;59(5):852-71.
- Guillot B, Dalac S, Denis MG, Dupuy A, Emile JF, De La Fouchardiere A, et al. French updated recommendations in Stage I to III melanoma treatment and management. J Eur Acad Dermatol Venereol. 2017;31(4):594-602.
- Park KG, Blessing K, Kernohan NM. Surgical aspects of subungual malignant melanomas. The Scottish Melanoma Group. Ann Surg. 1992;216(6):692-5.
- Jo G, Cho SI, Choi S, Mun JH. Functional surgery versus amputation for in situ or minimally invasive nail melanoma: A meta-analysis. J Am Acad Dermatol. 2019;81(4):917-22.
- Kimyai-Asadi A, Katz T, Goldberg LH, Ayala GB, Wang SQ, Vujevich JJ, et al. Margin involvement after the excision of melanoma in situ: the need for complete en face examination of the surgical margins. Dermatol Surg. 2007;33(12):1434-9; discussion 9-41.
- Blank CU, Lucas MW, Scolyer RA, van de Wiel BA, Menzies AM, Lopez-Yurda M, et al. Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma. N Engl J Med. 2024;391(18):1696-708.
| Case | Age | Work | Domi- nant mem- ber | Sex | His- tory | Loca- tion | Biopsy before WLE | Histopathol- ogy after WLE |
Stage 1 surgery (Margins) (Duration) |
Stage 2 surgery | Opera- tion in- terval | Side effects / complica- tions | Score (%) |
Cumu- lated Length of time off work |
Fol- low-up Period |
| 1 | 73 | Retired | Right | M | HTN | Right Fg1 | Inva- sive SUM | Invasive SUM Breslow = 1,2mm |
WLE (NA) | Amputa- tion trans P1 (17 min) |
45 days | Brain metas- tasis, death | NA | None | 24 months |
| 2 | 68 | Retired | Right | F | None | Right Fg1 | SUM in situ | SUM in situ | WLE + Dermal Matrix (29 min) |
recovery of operat- ing mar- gins + FTSG (33 min) |
45 days | Hyposensi- tivity of the pinch, drop- ping objects Cold Hyper- sensitivity |
MWS: 85 Quick DASH: 41 |
None | 29 months |
| 3 | 48 | Notary | Right | F | None | Left Fg4 | SUM in situ | SUM in situ | WLE (5mm) (25 min) |
FTSG (24 min) |
15 days | Cold and Warm Hy- persensitiv- ity Tactical hy- persensitiv- ity of dorsal fingertip |
MWS: 80 Quick DASH :41 |
9 Weeks | 18 months |
| 4 | 66 | Retired | Right | F | None | Right Fg1 | SUM in situ | Invasive SUM Breslow = 0.7mm |
WLE (6mm) + Dermal Matrix (29 min) |
FTSG (33 min) |
21 days | None | MWS :75 Quick DASH: 18 |
None | 19 months |
| 5 | 54 | Commer- cial | Right | M | None | Right Fg1 | SUM in situ | SUM in situ | WLE + Dermal Matrix (35 min) |
FTSG (28 min) |
21 days | None | NA | NA | 13 months |
| 6 | 80 | Retired | Right | M | HTN, COPD | Right Fg2 | SUM in situ | SUM in situ | WLE + Fascio-adi- pous flap (41 min) |
None | None | Cold hyper- sensitivity Tactical hy- persensitiv- ity of dorsal fingertip |
MWS :75 Quick Dash: 2.3 |
None | 8 months |
| 7 | 74 | Retired | NA | F | HTN | Left T1 | SUM in situ | SUM in situ | WLE + Inter meta- tarsal flap (68 min) |
None | None | None | AOFAS: 90 | None | 25 months |
| 8 | 49 | Commer- cial | NA | F | Dia- betic | Right T1 | Inva- sive SUM | Invasive SUM Bres- low=0.8mm |
WLE + Inter meta- tarsal flap (55 min) |
None | None | None | AOFAS: 80 | 6 Weeks | 24 months |
| 9 | 60 | Retired | NA | M | None | Right T1 | SUM in situ | SUM in situ | WLE + Dermal Matrix + STSG (39 min) |
None | None | None | AOFAS: 90 | None (stopped for per- sonal reasons) |
13 months |
| 10 | 52 | Nurse | NA | F | None | Left T2 | SUM in situ | SUM in situ | WLE+ Pulp ad- vancement flap |
None | None | Nail rem- nant | AOFAS: 87 | 1 day | 7 months |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).